EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies

Evan C Chen, Jacqueline S Garcia

Acta Haematologica · 2024 · 147 (2) · 198-218

DOI: 10.1159/000533990 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Haematologica, online erschienen am 06.09.2023. Verfasst von Evan C Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: In the past decade, there have been significant breakthroughs in immunotherapies for B-cell lymphoid malignancies and multiple myeloma, but progress has been much less for acute myeloid leukemia (AML). Nevertheless, challenge begets innovation and several therapeutic strategies are under investigation. Summary: In this review, we review the state of the art in AML immunotherapy including CD33- and CD123-targeted agents, immune checkpoint inhibition, and adoptive cell therapy strategies. We also share conceptual frameworks for approaching the growing catalog of investigational AML immunotherapies and propose future directions for the field. Key Messages: Immunotherapies for AML face significant challenges but novel strategies are in development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsLeukemia, Myeloid, AcuteHumansImmunotherapyMolecular Targeted TherapyImmunotherapy, Adoptive

Stichwörter der Autor:innen

Acute myeloid leukemiaAdoptive cell therapyAntibody-drug conjugateBispecific antibodyImmunotherapy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Zitieren

APA

Chen, E. C., & Garcia, J. S. (2024). Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies. Acta Haematologica, 147(2), 198-218. https://doi.org/10.1159/000533990

Vancouver

Chen EC, Garcia JS. Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies. Acta Haematologica. 2024;147(2):198-218. doi:10.1159/000533990

BibTeX
@article{Chen2024,
  author = {Chen, Evan C and Garcia, Jacqueline S},
  title = {Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies},
  journal = {Acta Haematologica},
  year = {2024},
  volume = {147},
  number = {2},
  pages = {198--218},
  doi = {10.1159/000533990}
}
Kostenlos starten →